Addressing Medication Affordability in Vulnerable Patients During COVID-19
Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're one of the...
Blogs By
What’s Your Market Access Digital Maturity?
When pharma brands become fully digitally enabled, market access pathways are optimized and providers have the tools they need to begin patients on your therapy rapidly and...
Improving Access to Mental Healthcare with OptimizeRx Financial Messaging
The 2022 State of Mental Health in America report highlights that 24.7% of adults with a mental illness in 2019 reported an unmet need for treatment—this number has seen a...
Making the Case for a Digital Revolution in Market Access
As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution. Companies face many...
Predict Patient Adherence Threats to Help HCPs Keep Patients on Course
Non-adherence to prescribed therapy can create extraordinary risks for patients. Even when provided with correct diagnoses and effective treatment plans, patients can often...
Inefficient Access Pathways Cost More Than Just HCP Time and Effort
There may be no greater threat to patient outcomes than the current barriers to therapy access—especially for specialty medications.
Discover Patients (and Their Providers) When They Are Poised to Change Therapies
Every day, patients switch to new therapies because of disease progression, side effects, affordability or other factors—potentially delaying patient recoveries, negatively...
Reducing Misdiagnosis with AI-Driven Patient Journey Mapping
It’s a problem with an enormous impact on patients that has been nearly impossible to solve: Brand-eligible patients are out there, but they’ve been misdiagnosed or, even...
Dynamic HCP Targeting — Here's the Secret to AI in Pharma Marketing
AI in Pharma Marketing is a Hot Topic – But Execution Lags Behind Ideation
If you’re a life science marketer, chances are you’ve been hearing about the difference artificial...
HCP Targeting: Be there when your ideal patient and provider meet
Unlocking the Full Potential with Artificial Intelligence in Pharma Marketing
At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to present on how...
Overcoming Challenges Related to Multiple Sclerosis Treatment: The Complete Picture
Key Themes and Takeways from Our Multiple Sclerosis Series
In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored three key areas...
Overcoming Challenges Related to Multiple Sclerosis Treatment: Patient Adherence
Part Three of Our Multiple Sclerosis Series
In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness...